Trials / Conditions / Oligometastatic Prostate Carcinoma

Oligometastatic Prostate Carcinoma

11 registered clinical trials studyying Oligometastatic Prostate Carcinoma — 6 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Addressing Health Literacy With a Tailored Survivorship Care Plan NCT06674863	Emory University	N/A
Recruiting	Accuracy of 18F-rhPSMA-7.3 PET/ MRI for Prediction of Lymph Node Metastasis in Localized High-Risk Prostate Ca NCT06389786	Mayo Clinic	N/A
Not Yet Recruiting	Neoadjuvant Radiohormonal Therapy for Oligometastatic Prostate Cancer NCT05707468	Changhai Hospital	N/A
Recruiting	Risk Stratified De-escalated Hormone Therapy With Radiation Therapy for the Treatment of Prostate Cancer NCT06369610	Mayo Clinic	Phase 2
Active Not Recruiting	[Ac-225]-PSMA-62 Trial in Oligometastatic Hormone Sensitive and Metastatic Castration Resistant Prostate Cance NCT06229366	Eli Lilly and Company	Phase 1
Recruiting	SBRT Versus Hypofractionated Radiotherapy for Biochemically Recurrent or Oligometastatic Prostate Adenocarcino NCT06205316	Mayo Clinic	Phase 3
Recruiting	OLIGOS: Impact of Treatment on Primary Tumour in Patients With Newly Diagnosed Oligometastatic Neoplasia of th NCT06273345	Istituto Oncologico Veneto IRCCS	—
Active Not Recruiting	177-Lutetium-PSMA Before Stereotactic Body Radiotherapy for the Treatment of Oligorecurrent Prostate Cancer, T NCT05496959	Jonsson Comprehensive Cancer Center	Phase 2
Active Not Recruiting	Testing the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, NCT05053152	NRG Oncology	Phase 2
Withdrawn	Androgen Deprivation Therapy and Apalutamide With or Without Radiation Therapy for the Treatment of Biochemica NCT04585932	M.D. Anderson Cancer Center	Phase 2
Active Not Recruiting	A Study to Evaluate Hypofractionated Proton Therapy or IMRT for Recurrent, Oligometastatic Prostate Cancer NCT04190446	Mayo Clinic	Phase 2